R. Califf and R. Harrington, Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes, Am J Cardiol, vol.96, issue.9, pp.1200-1206, 2005.

J. Eikelboom, S. Mehta, S. Anand, C. Xie, K. Fox et al., Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes, Circulation, vol.114, issue.8, pp.774-782, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.612812

K. Huber, P. Juni, A. Kastrati, J. Knuuti, M. Lenzen et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, vol.33, issue.20, pp.2569-2619, 2012.

G. Montalescot, S. Wiviott, E. Braunwald, S. Murphy, C. Gibson et al., Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial, The Lancet, vol.373, issue.9665, pp.723-731, 2009.
DOI : 10.1016/S0140-6736(09)60441-4

E. Ramazzotti and D. Antoniucci, Residual platelet reactivity, bleedings, and adherence to treatment in patients having coronary stent implantation treated with prasugrel, Am J Cardiol, vol.2012109, issue.2, pp.214-222

M. Laine, P. Michelet, J. Bessereau, G. Lemesle, F. Dignat-george et al., Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1- year follow-up in patients receiving prasugrel, J Thromb Haemost, vol.2012, issue.10, pp.101999-2005

M. Alessi, P. Morange, J. Collet, and G. Montalescot, Prasugrel monitoring and bleeding in real world patients, Am J Cardiol, vol.2013111, issue.1, pp.38-44

V. Menon, E. Nikolsky, V. Serebruany, M. Valgimigli, P. Vranckx et al., Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium, Circulation, vol.123, issue.23, pp.2736-2747, 2011.

T. Robertson and M. Terrin, Thrombolysis in Myocardial Infarction (TIMI) Trial?phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase, J Am Coll Cardiol, vol.11, issue.1, pp.1-11, 1988.

S. Mendis, Third universal definition of myocardial infarction, Eur Heart J, vol.33, issue.20, pp.2551-2567, 2012.

D. Lin, L. Wei, and Z. Ying, Checking the Cox model with cumulative sums of martingale-based residuals, Biometrika, vol.80, issue.3, pp.557-72, 1993.
DOI : 10.1093/biomet/80.3.557

S. Wiviott, E. Braunwald, C. Mccabe, G. Montalescot, W. Ruzyllo et al., Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes, TRITON-TIMI 38 Investigators. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes, pp.2001-2015, 2007.
DOI : 10.1056/NEJMoa0706482

L. Payot, N. Vignolles, J. Metzger, and D. Thomas, Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes, Circulation, vol.110, issue.16, pp.2361-2367, 2004.

P. Steg, S. James, R. Harrington, D. Ardissino, R. Becker et al., Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis, Circulation, vol.122, issue.21, pp.2131-2141, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.927582

E. Ramazzotti and D. Antoniucci, Residual Platelet Reactivity, Bleedings, and Adherence to Treatment in Patients Having Coronary Stent Implantation Treated With Prasugrel, Am J Cardiol, vol.109, issue.2, pp.214-218, 2012.

J. Mega, E. Braunwald, S. Wiviott, J. Bassand, D. Bhatt et al., Rivaroxaban in Patients with a Recent Acute Coronary Syndrome, ATLAS ACS 2?TIMI 51 Investigators. Rivaroxaban in Patients with a Recent Acute Coronary Syndrome, pp.9-19, 2012.
DOI : 10.1056/NEJMoa1112277

R. Goldberg, Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE), Eur Heart J, vol.24, issue.20, pp.1815-1823, 2003.

G. Montalescot and E. Braunwald, Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality: Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel ? Thrombolysis in Myocardial Infarction, Circulation, vol.38123, issue.23, pp.2681-2689, 2011.